Loading…
Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1
Central hyposomatotropism and hypothyroidism have been inferred in long-stay intensive care patients. Pronounced hypoandrogenism presumably also contributes to the catabolic state of critical illness. Accordingly, the present study appraises the mechanism(s) of failure of the gonadotropic axis in pr...
Saved in:
Published in: | The journal of clinical endocrinology and metabolism 2001-07, Vol.86 (7), p.3217-3226 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c1700-8cd3422241765472230cca8bdc10802323e33f7606574d0b3e3c479ba26938df3 |
---|---|
cites | cdi_FETCH-LOGICAL-c1700-8cd3422241765472230cca8bdc10802323e33f7606574d0b3e3c479ba26938df3 |
container_end_page | 3226 |
container_issue | 7 |
container_start_page | 3217 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 86 |
creator | Van den Berghe, Greet Weekers, Frank Baxter, Robert C. Wouters, Pieter Iranmanesh, Ali Bouillon, Roger Veldhuis, Johannes D. |
description | Central hyposomatotropism and hypothyroidism have been
inferred in long-stay intensive care patients. Pronounced
hypoandrogenism presumably also contributes to the catabolic state of
critical illness. Accordingly, the present study appraises the
mechanism(s) of failure of the gonadotropic axis in prolonged
critically ill men by assessing the effects of pulsatile GnRH treatment
in this unique clinical context.
To this end, 15 critically ill men (mean ± sd
age, 67 ± 12 yr; intensive care unit stay, 25 ± 9 days)
participated, with baseline values compared with those of 50 age- and
BMI-matched healthy men. Subjects were randomly allocated to 5 days of
placebo or pulsatile iv GnRH administration (0.1 μg/kg every 90 min).
LH, GH, and TSH secretion was quantified by deconvolution analysis of
serum hormone concentration-time series obtained by sampling every 20
min from 2100–0600 h at baseline and on nights 1 and 5 of treatment.
Serum concentrations of gonadal and adrenal steroids, T4,
T3, insulin-like growth factor I (IGF), and IGF-binding
proteins as well as circulating levels of cytokines and selected
metabolic markers were measured.
During prolonged critical illness, pulsatile LH secretion and
mean LH concentrations (1.8 ± 2.2 vs. 6.0 ±
2.2 IU/L) were low in the face of extremely low circulating total
testosterone (0.27 ± 0.18 vs. 12.7 ± 4.07
nmol/L; P < 0.0001) and relatively low estradiol
(E2; 58.3 ± 51.9 vs. 85.7 ± 18.6
pmol/L; P = 0.009) and sex hormone-binding globulin
(39.1 ± 11.7 vs. 48.6 ± 27.8 nmol/L;
P = 0.01). The molar ratio of E2/T was
elevated 37-fold in ill men (P < 0.0001) and
correlated negatively with the mean serum LH concentrations (r =−
0.82; P = 0.0002). Pulsatile GH and TSH secretion
were suppressed (P ≤ 0.0004), as were mean serum
IGF-I, IGF-binding protein-3, and acid-labile subunit concentrations;
thyroid hormone levels; and dehydroepiandrosterone sulfate. Morning
cortisol was within the normal range. Serum interleukin-1β
concentrations were normal, whereas interleukin-6 and tumor necrosis
factor-α were elevated. Serum tumor necrosis factor-α was
positively correlated with the molar E2/testosterone ratio
and with type 1 procollagen; the latter was elevated, whereas
osteocalcin was decreased. Ureagenesis and breakdown of bone were
increased. C-Reactive protein and white blood cell counts were
elevated; serum lactate levels were normal.
Intermittent iv GnRH administration increased pulsatile
LH secretion compared with placebo by an incr |
doi_str_mv | 10.1210/jcem.86.7.7680 |
format | article |
fullrecord | <record><control><sourceid>endocrinepress_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1210_jcem_86_7_7680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1210_jcem_86_7_7680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1700-8cd3422241765472230cca8bdc10802323e33f7606574d0b3e3c479ba26938df3</originalsourceid><addsrcrecordid>eNp1kc9OGzEQxq2KSg201579At76z-5694hCIUggIgRSbyvHng2OvHZkO1R5Px4ML-HKaTTS_L5vZj6EfjNaMc7on52GqeraSlay7eg3tGB93RDJenmGFpRyRnrJ__1A5yntKGV13YgFeru2r0Cu1BGvDy6pbB3gm-CVCTmGvfXkERyoZP0Wr0Kcggd8aSbrbcqxTAePn_0rWJfwMkwb68Hg1XEf8otyarKarG0-2KzikXyoKoevYASdU-EMRHecldcxjOHgT6jyJoYtFIcJW4_vweP_Nr_MQy74bTFYRputLlK3znlIif1E30flEvz6rBfo-frv03JF7h5ubpeXd0QzSSnptBE157xmsm1qybmgWqtuYzSjHeWCCxBilC1tG1kbuimtrmW_UbztRWdGcYGqk66OIaUI47CPdirHDYwOcwbDnMHQtYMc5gwK0JwA8CboWN6zj2XhYRcO0ZdNv-LeATBwkhI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1</title><source>Oxford Journals Online</source><creator>Van den Berghe, Greet ; Weekers, Frank ; Baxter, Robert C. ; Wouters, Pieter ; Iranmanesh, Ali ; Bouillon, Roger ; Veldhuis, Johannes D.</creator><creatorcontrib>Van den Berghe, Greet ; Weekers, Frank ; Baxter, Robert C. ; Wouters, Pieter ; Iranmanesh, Ali ; Bouillon, Roger ; Veldhuis, Johannes D.</creatorcontrib><description>Central hyposomatotropism and hypothyroidism have been
inferred in long-stay intensive care patients. Pronounced
hypoandrogenism presumably also contributes to the catabolic state of
critical illness. Accordingly, the present study appraises the
mechanism(s) of failure of the gonadotropic axis in prolonged
critically ill men by assessing the effects of pulsatile GnRH treatment
in this unique clinical context.
To this end, 15 critically ill men (mean ± sd
age, 67 ± 12 yr; intensive care unit stay, 25 ± 9 days)
participated, with baseline values compared with those of 50 age- and
BMI-matched healthy men. Subjects were randomly allocated to 5 days of
placebo or pulsatile iv GnRH administration (0.1 μg/kg every 90 min).
LH, GH, and TSH secretion was quantified by deconvolution analysis of
serum hormone concentration-time series obtained by sampling every 20
min from 2100–0600 h at baseline and on nights 1 and 5 of treatment.
Serum concentrations of gonadal and adrenal steroids, T4,
T3, insulin-like growth factor I (IGF), and IGF-binding
proteins as well as circulating levels of cytokines and selected
metabolic markers were measured.
During prolonged critical illness, pulsatile LH secretion and
mean LH concentrations (1.8 ± 2.2 vs. 6.0 ±
2.2 IU/L) were low in the face of extremely low circulating total
testosterone (0.27 ± 0.18 vs. 12.7 ± 4.07
nmol/L; P < 0.0001) and relatively low estradiol
(E2; 58.3 ± 51.9 vs. 85.7 ± 18.6
pmol/L; P = 0.009) and sex hormone-binding globulin
(39.1 ± 11.7 vs. 48.6 ± 27.8 nmol/L;
P = 0.01). The molar ratio of E2/T was
elevated 37-fold in ill men (P < 0.0001) and
correlated negatively with the mean serum LH concentrations (r =−
0.82; P = 0.0002). Pulsatile GH and TSH secretion
were suppressed (P ≤ 0.0004), as were mean serum
IGF-I, IGF-binding protein-3, and acid-labile subunit concentrations;
thyroid hormone levels; and dehydroepiandrosterone sulfate. Morning
cortisol was within the normal range. Serum interleukin-1β
concentrations were normal, whereas interleukin-6 and tumor necrosis
factor-α were elevated. Serum tumor necrosis factor-α was
positively correlated with the molar E2/testosterone ratio
and with type 1 procollagen; the latter was elevated, whereas
osteocalcin was decreased. Ureagenesis and breakdown of bone were
increased. C-Reactive protein and white blood cell counts were
elevated; serum lactate levels were normal.
Intermittent iv GnRH administration increased pulsatile
LH secretion compared with placebo by an increment of +8.1 ± 8.1
IU/L at 24 h (P = 0.001). This increase was
only partially maintained after 5 days of treatment. GnRH pulses
transiently increased serum testosterone by +174% on day 2
(P = 0.05), whereas all other endocrine parameters
remained unaltered. GnRH tended to increase type 1 procollagen
(P = 0.06), but did not change serum osteocalcin
levels or bone breakdown. Ureagenesis was suppressed
(P < 0.0001), and white blood cell count
(P = 0.0001), C-reactive protein
(P = 0.03), and lactate level
(P = 0.01) were increased by GnRH compared with
placebo infusions.
In conclusion, hypogonadotropic hypogonadism in prolonged
critically ill men is only partially overcome with exogenous iv GnRH
pulses, pointing to combined hypothalamic-pituitary-gonadal origins of
the profound hypoandrogenism evident in this context. In view of
concomitant central hyposomatotropism and hypothyroidism, evaluating
the effectiveness of pulsatile GnRH intervention together with GH and
TSH secretagogues will be important.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jcem.86.7.7680</identifier><language>eng</language><publisher>Endocrine Society</publisher><ispartof>The journal of clinical endocrinology and metabolism, 2001-07, Vol.86 (7), p.3217-3226</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1700-8cd3422241765472230cca8bdc10802323e33f7606574d0b3e3c479ba26938df3</citedby><cites>FETCH-LOGICAL-c1700-8cd3422241765472230cca8bdc10802323e33f7606574d0b3e3c479ba26938df3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Van den Berghe, Greet</creatorcontrib><creatorcontrib>Weekers, Frank</creatorcontrib><creatorcontrib>Baxter, Robert C.</creatorcontrib><creatorcontrib>Wouters, Pieter</creatorcontrib><creatorcontrib>Iranmanesh, Ali</creatorcontrib><creatorcontrib>Bouillon, Roger</creatorcontrib><creatorcontrib>Veldhuis, Johannes D.</creatorcontrib><title>Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1</title><title>The journal of clinical endocrinology and metabolism</title><description>Central hyposomatotropism and hypothyroidism have been
inferred in long-stay intensive care patients. Pronounced
hypoandrogenism presumably also contributes to the catabolic state of
critical illness. Accordingly, the present study appraises the
mechanism(s) of failure of the gonadotropic axis in prolonged
critically ill men by assessing the effects of pulsatile GnRH treatment
in this unique clinical context.
To this end, 15 critically ill men (mean ± sd
age, 67 ± 12 yr; intensive care unit stay, 25 ± 9 days)
participated, with baseline values compared with those of 50 age- and
BMI-matched healthy men. Subjects were randomly allocated to 5 days of
placebo or pulsatile iv GnRH administration (0.1 μg/kg every 90 min).
LH, GH, and TSH secretion was quantified by deconvolution analysis of
serum hormone concentration-time series obtained by sampling every 20
min from 2100–0600 h at baseline and on nights 1 and 5 of treatment.
Serum concentrations of gonadal and adrenal steroids, T4,
T3, insulin-like growth factor I (IGF), and IGF-binding
proteins as well as circulating levels of cytokines and selected
metabolic markers were measured.
During prolonged critical illness, pulsatile LH secretion and
mean LH concentrations (1.8 ± 2.2 vs. 6.0 ±
2.2 IU/L) were low in the face of extremely low circulating total
testosterone (0.27 ± 0.18 vs. 12.7 ± 4.07
nmol/L; P < 0.0001) and relatively low estradiol
(E2; 58.3 ± 51.9 vs. 85.7 ± 18.6
pmol/L; P = 0.009) and sex hormone-binding globulin
(39.1 ± 11.7 vs. 48.6 ± 27.8 nmol/L;
P = 0.01). The molar ratio of E2/T was
elevated 37-fold in ill men (P < 0.0001) and
correlated negatively with the mean serum LH concentrations (r =−
0.82; P = 0.0002). Pulsatile GH and TSH secretion
were suppressed (P ≤ 0.0004), as were mean serum
IGF-I, IGF-binding protein-3, and acid-labile subunit concentrations;
thyroid hormone levels; and dehydroepiandrosterone sulfate. Morning
cortisol was within the normal range. Serum interleukin-1β
concentrations were normal, whereas interleukin-6 and tumor necrosis
factor-α were elevated. Serum tumor necrosis factor-α was
positively correlated with the molar E2/testosterone ratio
and with type 1 procollagen; the latter was elevated, whereas
osteocalcin was decreased. Ureagenesis and breakdown of bone were
increased. C-Reactive protein and white blood cell counts were
elevated; serum lactate levels were normal.
Intermittent iv GnRH administration increased pulsatile
LH secretion compared with placebo by an increment of +8.1 ± 8.1
IU/L at 24 h (P = 0.001). This increase was
only partially maintained after 5 days of treatment. GnRH pulses
transiently increased serum testosterone by +174% on day 2
(P = 0.05), whereas all other endocrine parameters
remained unaltered. GnRH tended to increase type 1 procollagen
(P = 0.06), but did not change serum osteocalcin
levels or bone breakdown. Ureagenesis was suppressed
(P < 0.0001), and white blood cell count
(P = 0.0001), C-reactive protein
(P = 0.03), and lactate level
(P = 0.01) were increased by GnRH compared with
placebo infusions.
In conclusion, hypogonadotropic hypogonadism in prolonged
critically ill men is only partially overcome with exogenous iv GnRH
pulses, pointing to combined hypothalamic-pituitary-gonadal origins of
the profound hypoandrogenism evident in this context. In view of
concomitant central hyposomatotropism and hypothyroidism, evaluating
the effectiveness of pulsatile GnRH intervention together with GH and
TSH secretagogues will be important.</description><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kc9OGzEQxq2KSg201579At76z-5694hCIUggIgRSbyvHng2OvHZkO1R5Px4ML-HKaTTS_L5vZj6EfjNaMc7on52GqeraSlay7eg3tGB93RDJenmGFpRyRnrJ__1A5yntKGV13YgFeru2r0Cu1BGvDy6pbB3gm-CVCTmGvfXkERyoZP0Wr0Kcggd8aSbrbcqxTAePn_0rWJfwMkwb68Hg1XEf8otyarKarG0-2KzikXyoKoevYASdU-EMRHecldcxjOHgT6jyJoYtFIcJW4_vweP_Nr_MQy74bTFYRputLlK3znlIif1E30flEvz6rBfo-frv03JF7h5ubpeXd0QzSSnptBE157xmsm1qybmgWqtuYzSjHeWCCxBilC1tG1kbuimtrmW_UbztRWdGcYGqk66OIaUI47CPdirHDYwOcwbDnMHQtYMc5gwK0JwA8CboWN6zj2XhYRcO0ZdNv-LeATBwkhI</recordid><startdate>200107</startdate><enddate>200107</enddate><creator>Van den Berghe, Greet</creator><creator>Weekers, Frank</creator><creator>Baxter, Robert C.</creator><creator>Wouters, Pieter</creator><creator>Iranmanesh, Ali</creator><creator>Bouillon, Roger</creator><creator>Veldhuis, Johannes D.</creator><general>Endocrine Society</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200107</creationdate><title>Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1</title><author>Van den Berghe, Greet ; Weekers, Frank ; Baxter, Robert C. ; Wouters, Pieter ; Iranmanesh, Ali ; Bouillon, Roger ; Veldhuis, Johannes D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1700-8cd3422241765472230cca8bdc10802323e33f7606574d0b3e3c479ba26938df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van den Berghe, Greet</creatorcontrib><creatorcontrib>Weekers, Frank</creatorcontrib><creatorcontrib>Baxter, Robert C.</creatorcontrib><creatorcontrib>Wouters, Pieter</creatorcontrib><creatorcontrib>Iranmanesh, Ali</creatorcontrib><creatorcontrib>Bouillon, Roger</creatorcontrib><creatorcontrib>Veldhuis, Johannes D.</creatorcontrib><collection>CrossRef</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van den Berghe, Greet</au><au>Weekers, Frank</au><au>Baxter, Robert C.</au><au>Wouters, Pieter</au><au>Iranmanesh, Ali</au><au>Bouillon, Roger</au><au>Veldhuis, Johannes D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><date>2001-07</date><risdate>2001</risdate><volume>86</volume><issue>7</issue><spage>3217</spage><epage>3226</epage><pages>3217-3226</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Central hyposomatotropism and hypothyroidism have been
inferred in long-stay intensive care patients. Pronounced
hypoandrogenism presumably also contributes to the catabolic state of
critical illness. Accordingly, the present study appraises the
mechanism(s) of failure of the gonadotropic axis in prolonged
critically ill men by assessing the effects of pulsatile GnRH treatment
in this unique clinical context.
To this end, 15 critically ill men (mean ± sd
age, 67 ± 12 yr; intensive care unit stay, 25 ± 9 days)
participated, with baseline values compared with those of 50 age- and
BMI-matched healthy men. Subjects were randomly allocated to 5 days of
placebo or pulsatile iv GnRH administration (0.1 μg/kg every 90 min).
LH, GH, and TSH secretion was quantified by deconvolution analysis of
serum hormone concentration-time series obtained by sampling every 20
min from 2100–0600 h at baseline and on nights 1 and 5 of treatment.
Serum concentrations of gonadal and adrenal steroids, T4,
T3, insulin-like growth factor I (IGF), and IGF-binding
proteins as well as circulating levels of cytokines and selected
metabolic markers were measured.
During prolonged critical illness, pulsatile LH secretion and
mean LH concentrations (1.8 ± 2.2 vs. 6.0 ±
2.2 IU/L) were low in the face of extremely low circulating total
testosterone (0.27 ± 0.18 vs. 12.7 ± 4.07
nmol/L; P < 0.0001) and relatively low estradiol
(E2; 58.3 ± 51.9 vs. 85.7 ± 18.6
pmol/L; P = 0.009) and sex hormone-binding globulin
(39.1 ± 11.7 vs. 48.6 ± 27.8 nmol/L;
P = 0.01). The molar ratio of E2/T was
elevated 37-fold in ill men (P < 0.0001) and
correlated negatively with the mean serum LH concentrations (r =−
0.82; P = 0.0002). Pulsatile GH and TSH secretion
were suppressed (P ≤ 0.0004), as were mean serum
IGF-I, IGF-binding protein-3, and acid-labile subunit concentrations;
thyroid hormone levels; and dehydroepiandrosterone sulfate. Morning
cortisol was within the normal range. Serum interleukin-1β
concentrations were normal, whereas interleukin-6 and tumor necrosis
factor-α were elevated. Serum tumor necrosis factor-α was
positively correlated with the molar E2/testosterone ratio
and with type 1 procollagen; the latter was elevated, whereas
osteocalcin was decreased. Ureagenesis and breakdown of bone were
increased. C-Reactive protein and white blood cell counts were
elevated; serum lactate levels were normal.
Intermittent iv GnRH administration increased pulsatile
LH secretion compared with placebo by an increment of +8.1 ± 8.1
IU/L at 24 h (P = 0.001). This increase was
only partially maintained after 5 days of treatment. GnRH pulses
transiently increased serum testosterone by +174% on day 2
(P = 0.05), whereas all other endocrine parameters
remained unaltered. GnRH tended to increase type 1 procollagen
(P = 0.06), but did not change serum osteocalcin
levels or bone breakdown. Ureagenesis was suppressed
(P < 0.0001), and white blood cell count
(P = 0.0001), C-reactive protein
(P = 0.03), and lactate level
(P = 0.01) were increased by GnRH compared with
placebo infusions.
In conclusion, hypogonadotropic hypogonadism in prolonged
critically ill men is only partially overcome with exogenous iv GnRH
pulses, pointing to combined hypothalamic-pituitary-gonadal origins of
the profound hypoandrogenism evident in this context. In view of
concomitant central hyposomatotropism and hypothyroidism, evaluating
the effectiveness of pulsatile GnRH intervention together with GH and
TSH secretagogues will be important.</abstract><pub>Endocrine Society</pub><doi>10.1210/jcem.86.7.7680</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2001-07, Vol.86 (7), p.3217-3226 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_crossref_primary_10_1210_jcem_86_7_7680 |
source | Oxford Journals Online |
title | Five-Day Pulsatile Gonadotropin-Releasing Hormone Administration Unveils Combined Hypothalamic-Pituitary-Gonadal Defects Underlying Profound Hypoandrogenism in Men with Prolonged Critical Illness1 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T15%3A07%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-endocrinepress_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Five-Day%20Pulsatile%20Gonadotropin-Releasing%20Hormone%20Administration%20Unveils%20Combined%20Hypothalamic-Pituitary-Gonadal%20Defects%20Underlying%20Profound%20Hypoandrogenism%20in%20Men%20with%20Prolonged%20Critical%20Illness1&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Van%20den%20Berghe,%20Greet&rft.date=2001-07&rft.volume=86&rft.issue=7&rft.spage=3217&rft.epage=3226&rft.pages=3217-3226&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/jcem.86.7.7680&rft_dat=%3Cendocrinepress_cross%3E10_1210_jcem_86_7_7680%3C/endocrinepress_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1700-8cd3422241765472230cca8bdc10802323e33f7606574d0b3e3c479ba26938df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |